Toronto Stocks Flat; ProMIS Neurosciences Drops on TSX Delisting
By Adriano Marchese
Toronto stocks were hovering around flat mid-trading on Monday with a mixed performance from Canada's different sectors. In the session, health technology, producer manufacturing and tech services were leading the gainers, offset by losses primarily in the consumer services, communications and utilities sectors.
At midday, Canada's S&P/TSX Composite Index was 0.04% lower at 19822.60. The blue-chip S&P/TSX 60 slid 0.12% to 1190.27.
ProMIS Neurosciences shares were 19% lower in Toronto at 3.90 Canadian dollars ($2.94) after the company said it would delist from the Toronto Stock Exchange and consolidate its trading on the Nasdaq exchange in the U.S.
Other market movers:
Dye & Durham shares were 2.5% higher at C$18.40 after the legal software company said it would sell its TM Group (UK) subsidiary to German alternative investment firm Aurelius Group for up to 91 million pounds ($116.8 million) after the U.K. Competition and Markets Authority ordered the divestiture to promote competition in property search services.
Shares of Vermilion Energy rose by 3.1% to C$17.67 after the oil and gas producer said it plans to launch a share repurchase program to buy back up to 10% of its shares over the course of a one-year period.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
July 10, 2023 12:16 ET (16:16 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits